Buy & Sell Diastika Biotekindo Tbk. - CHEK Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp201.31B | +30.05% |
| Cost of Revenue | Rp124.17B | +31.99% |
| Gross Profit | Rp77.14B | +27.04% |
| General Expenses, Depreciation, Interest | Rp53.99B | +37.64% |
| Operating Profit | Rp23.15B | +7.72% |
| Other Income | -Rp5.83B | +163.99% |
| EBT | Rp18.4B | -4.57% |
| Taxes | -Rp4.38B | -206.56% |
| Net Income | Rp14.02B | -7.59% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp259.53B | +118.44% |
| Total Liabilities | Rp48.45B | +89.5% |
| Total Equity | Rp211.08B | +126.38% |
| Total Liabilities & Total Equity | Rp259.53B | +118.44% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp43.15B | -430.85% |
| CF from Investment | Rp27.27B | +79.38% |
| CF from Financing | Rp121.43B | -78954.06% |
| Net Cash Flow | Rp51.01B | -2305.33% |